Detailed information for compound 57515

Basic information

Technical information
  • TDR Targets ID: 57515
  • Name: 1-[2-[(3-chlorophenyl)-phenylmethoxy]ethyl]-2 -methyl-5-nitroimidazole
  • MW: 371.818 | Formula: C19H18ClN3O3
  • H donors: 0 H acceptors: 3 LogP: 4.18 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1cccc(c1)C(c1ccccc1)OCCn1c(C)ncc1[N+](=O)[O-]
  • InChi: 1S/C19H18ClN3O3/c1-14-21-13-18(23(24)25)22(14)10-11-26-19(15-6-3-2-4-7-15)16-8-5-9-17(20)12-16/h2-9,12-13,19H,10-11H2,1H3
  • InChiKey: ASIJIZKHURAAOW-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 1-[2-[(3-chlorophenyl)-phenyl-methoxy]ethyl]-2-methyl-5-nitro-imidazole
  • 1-{2-[alpha-(3-Chlorophenyl)phenylmethoxy]ethyl}-2-methyl-5-nitroimidazole
  • Diarylmethoxyethylmethylnitroimidazole (DAMNI) 7
  • AIDS121178
  • AIDS-121178

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Human immunodeficiency virus 1 Human immunodeficiency virus type 1 reverse transcriptase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Plasmodium yoelii integrase-related Get druggable targets OG5_139608 All targets in OG5_139608
Schistosoma mansoni hypothetical protein Get druggable targets OG5_139608 All targets in OG5_139608
Trypanosoma brucei RNA helicase, putative Get druggable targets OG5_139608 All targets in OG5_139608
Trypanosoma congolense RNA helicase, putative Get druggable targets OG5_139608 All targets in OG5_139608
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) 0.0675 1 1
Entamoeba histolytica fatty acid elongase, putative 0.0088 0.0669 0.5
Mycobacterium ulcerans beta-ketoacyl synthase-like protein 0.0675 1 1
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase 0.0675 1 1
Entamoeba histolytica fatty acid elongase, putative 0.0088 0.0669 0.5
Entamoeba histolytica fatty acid elongase, putative 0.0088 0.0669 0.5
Trypanosoma cruzi beta-ketoacyl synthase family protein, putative 0.007 0.0387 0.5
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0675 1 1
Mycobacterium leprae 3-oxoacyl-[acyl-carrier-protein] synthase 1 KasA (BETA-KETOACYL-ACP SYNTHASE) (KAS I) 0.0046 0 0.5
Brugia malayi Beta-ketoacyl synthase, N-terminal domain containing protein 0.007 0.0387 0.5
Entamoeba histolytica fatty acid elongase, putative 0.0088 0.0669 0.5
Mycobacterium leprae 3-oxoacyl-[acyl-carrier-protein] synthase 2 KasB (BETA-KETOACYL-ACP SYNTHASE) (KAS I) 0.0046 0 0.5
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative 0.0675 1 1
Toxoplasma gondii 3-oxoacyl-acyl-carrier protein synthase I/II, putative 0.007 0.0387 0.5
Trypanosoma cruzi beta-ketoacyl synthase family protein, putative 0.007 0.0387 0.5
Plasmodium falciparum beta-ketoacyl-ACP synthase III 0.0675 1 1
Trypanosoma brucei RNA helicase, putative 0.01 0.0864 1
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0675 1 1
Loa Loa (eye worm) beta-ketoacyl synthase domain-containing protein 0.007 0.0387 0.5
Schistosoma mansoni hypothetical protein 0.01 0.0864 1
Echinococcus granulosus 3 oxoacyl acyl carrier protein synthase 0.007 0.0387 0.5
Leishmania major beta-ketoacyl synthase family protein, putative,3-oxoacyl-acyl carrier protein synthase ii, putative 0.007 0.0387 0.5
Echinococcus multilocularis 3 oxoacyl (acyl carrier protein) synthase 0.007 0.0387 0.5
Entamoeba histolytica fatty acid elongase, putative 0.0088 0.0669 0.5

Activities

Activity type Activity value Assay description Source Reference
CC50 (functional) > 200 uM Dose required to reduce the viability of mock-infected cells by 50% ChEMBL. 11931611
CC50 (functional) > 200 uM Dose required to reduce the viability of mock-infected cells by 50% ChEMBL. 11931611
EC50 (functional) = 0.2 uM Dose required to achieve 50% protection of MT-4 cells from HIV-1 induced cytopathogenicity ChEMBL. 11931611
IC50 (binding) = 0.5 uM Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50% ChEMBL. 11931611
IC50 (binding) = 0.5 uM Dose required to inhibit the HIV-1 Reverse transcriptase activity by 50% ChEMBL. 11931611
Selectivity index (functional) > 1000 Selectivity Index of the compound (CC50:EC50 Ratio) ChEMBL. 11931611

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.